Poor antibiotic prescribing practices are putting patients at risk for allergic reactions, super-resistant infections, and deadly diarrhea cause by Clostridium difficile, according to new report from the Centers for Disease Control and Prevention (CDC).
Poor antibiotic prescribing practices are putting patients at risk for allergic reactions, super-resistant infections, and deadly diarrhea cause by Clostridiumdifficile, according to new report from the Centers for Disease Control and Prevention (CDC).
The CDC report said the inconsistent prescribing practices are also driving antibiotic resistance and that antibiotic prescribing practices need to be changed immediately.
According to the report:
To help hospitals improve in the area of antibiotic prescribing, CDC developed a checklist of core safety elements that each facility should have in place. CDC said every hospital should have an antibiotic stewardship program. That program should include the following elements:
Skyrizi Overtakes Humira in U.S. Sales Numbers
November 8th 2024For the first time, Skyrizi has replaced Humira as AbbVie’s sales driver, largely due to companies encouraging “product hopping” to avoid competition, creating concerns for the sustainability of the burgeoning adalimumab biosimilar market.
Read More
FDA Advisory Committee Votes Down Sotagliflozin in Type 1 Diabetes and CKD
November 1st 2024Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently reviewing the oral therapy as an adjunct to insulin to help control glycemic levels in adults with type 1 diabetes and chronic kidney disease. The agency’s goal date is Dec. 20, 2024.
Read More